1-4 of 4
Masahiro Yamada
Close
Sort by
Journal Articles

Tumor Suppressive Mir-7 Targeting PSME3 Improves the Efficacy of Histone Deacetylases Inhibitors in Multiple Myeloma

Masahiro Yamada, Sho Ikeda, Wataru Kuroki, Sayaka Iwama, Yuto Takahashi, Akihiro Kitadate, Fumito Abe, Hiroyuki Tagawa, Naoto Takahashi
Journal: Blood
Blood (2023) 142 (Supplement 1): 6592.
https://doi.org/10.1182/blood-2023-173475
Published: 2023
Journal Articles

Multiple Myeloma with 1q Gain/Amplification Shows Reduced CD38 Expression Via IL-6R Overexpression

Wataru Kuroki, Akihiro Kitadate, Masahiro Yamada, Sayaka Iwama, Yuto Takahashi, Yuki Fujioka, Takahiro Kobayashi, Sho Ikeda, Kentaro Narita, Kosei Matsue, Naoto Takahashi
Journal: Blood
Blood (2023) 142 (Supplement 1): 637.
https://doi.org/10.1182/blood-2023-173494
Published: 2023
Journal Articles

Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients

Clinical Trials & Observations
Satoshi Nishiwaki, Matsuyoshi Maeda, Masahiro Yamada, Shingo Okuno, Yasuhiko Harada, Kotaro Suzuki, Shingo Kurahashi, Fumihiro Urano, Shozo Okamura, Isamu Sugiura
Journal: Blood
Blood (2017) 129 (1): 126–128.
https://doi.org/10.1182/blood-2016-08-734947
Published: 2017
Journal Articles

Significance of Fecal Occult Blood Test Followed By Colonoscopy for Asymptomatic Dasatinib-Induced Hemorrhagic Colitis (CML1501 Study)

Satoshi Nishiwaki, Matsuyoshi Maeda, Masahiro Yamada, Shingo Okuno, MD, Yasuhiko Harada, MD, Kotaro Suzuki, Shingo Kurahashi, Fumihiro Urano, Shozo Okamura, Isamu Sugiura
Journal: Blood
Blood (2016) 128 (22): 1917.
https://doi.org/10.1182/blood.V128.22.1917.1917
Published: 2016